The herb that gave us the word 'adaptogen.' Regulatory recognition across three jurisdictions for fatigue, backed by 46 Soviet-era studies. Modern Western RCTs are mostly null.
Traditions: Traditional Chinese Medicine, Soviet phytomedicine, Korean traditional medicine (Hanbang), Japanese folk medicine
Ciwujia (刺五加) — qi and yang tonic for Spleen and Kidney deficiency. Used for weakness, debility, cold extremities, low back pain, insomnia, and convalescence.
Administered to cosmonauts, Olympic athletes, miners, and factory workers to enhance performance under stress. Brekhman coined 'adaptogen' from this research. Distributed as a registered medicine across the USSR; given to Chernobyl workers for immune support.
Gasi-ogapi (Korea) / Ezo-ukogi (Japan) — parallel tonic applications following TCM traditions, with modern use shaped by Soviet research rather than classical Kampo.
German Commission E (1991), WHO (2002), and EMA (2014) all formally recognize eleuthero for fatigue and declining work capacity — regulatory approval that's unusual for an adaptogen. The underlying evidence is split: 46 Soviet-era clinical studies broadly positive (physical endurance, cognitive stamina), largely inaccessible to Western audiences and not peer-reviewed by modern standards. Modern Western RCTs are mostly null. A consistent subgroup pattern emerges: moderate (not severe) fatigue and recreational (not elite) athletes are where positive signals appear.
2000 mg/day standardized extract for 2 months: no overall significant difference vs placebo (both groups improved substantially). Subgroup with moderate fatigue (n=45): significant benefit over placebo (P=0.04). Severe fatigue subgroup: no benefit.
800 mg/day for 8 weeks: +12% VO2 peak (P<0.05), +23% endurance time (P<0.05), glycogen-sparing shift toward fatty acid oxidation. Crossover design — no benefit visible until full 8-week course completed.
30 mL/day ethanolic extract for 4 weeks: 'drastic increase' in T lymphocytes (helper/inducer and cytotoxic), NK cells. No adverse effects at 6-month follow-up. Not replicated in subsequent controlled trials.
First English-language synthesis of 46 Soviet clinical studies (1962–1986, 29 placebo-controlled): 'appears to exhibit benefits for cognitive function and physical and mental endurance.' Caveat: not independently peer-reviewed by modern standards.
Most convenient form. Look for eleutheroside B + E content stated in mg — at 0.8% standardization, 200 mg delivers approximately 1.6 mg active markers. Quality varies enormously between brands; see Quality Matters.
The Soviet SHE extract (fluid extract 1:1, 40% ethanol) at 2 mL/day was the most common dose across 14 of 46 Soviet trials. Tincture (1:5) is more dilute — need 5× the volume for equivalent dose. Delivers moderate alcohol per day at tincture doses.
Traditional TCM preparation. Aqueous extraction favors polysaccharide (Eleutheran) fraction — the immune-relevant constituents — over eleutherosides. Different active profile than ethanolic extracts. Bitter, slightly woody, earthy taste.
The word “adaptogen” was invented for eleuthero. Soviet pharmacologist Israel Brekhman coined it in the 1960s to describe what this plant did in their research: a non-specific increase in the body’s resistance to diverse stressors. German Commission E (1991), WHO (2002), and EMA (2014) all formally recognize eleuthero for fatigue and declining capacity — regulatory approval that’s genuinely unusual for an adaptogen.
That’s the good news. The honest news is more complicated.
Soviet-era evidence (46 studies, 1962–1986): The first English-language synthesis of this literature found broad positive results for physical and mental endurance (Gerontakos 2021). But these studies weren’t peer-reviewed by modern standards, most haven’t been independently replicated in the West, and the most common dose tested — 2 mL/day of fluid extract — doesn’t map cleanly to modern commercial products.
Modern Western RCTs — mostly null or equivocal:
Where positive signals appear:
The pattern: Eleuthero may work best for people in the middle — moderate fatigue, recreational activity level, sustained performance demands rather than recovery from severe depletion. People who most want it (elite athletes, severe chronic fatigue, significant burnout) show the least benefit.
TCM (centuries): Ciwujia (刺五加) sits in the tonic herb category: bǔ yì yào, herbs that replenish what’s depleted. Specifically classified as qi and yang tonic for the Spleen and Kidney — Chinese medicine’s shorthand for digestive and constitutional vitality. Traditional indications include weakness, cold extremities, low back pain, poor appetite, insomnia, and recovery from illness. The overlap with “fatigue and declining work capacity” in modern regulatory language is real, not retrofitted.
Soviet phytomedicine (1960s–1980s): This is where eleuthero’s modern identity was forged. Brekhman’s team at the Soviet Far Eastern Scientific Centre chose it as a cost-effective alternative to scarce Panax ginseng. It was administered to cosmonauts preparing for extended missions, Olympic athletes, miners working in cold Siberian conditions, and factory workers at difficult posts. After Chernobyl, it was given to workers exposed to radiation.
The term “adaptogen” emerged from this program — not a marketing invention, but a working hypothesis: this plant produces non-specific resistance to diverse environmental and physiological stressors. 46 clinical studies followed over two decades.
Korea (Gasi-ogapi) and Japan (Ezo-ukogi): Parallel tonic applications that largely follow TCM traditions, with modern Japanese phytomedicine shaped more by Soviet research than classical Kampo. Japan’s commercial market has a documented species identification problem: approximately 30% of products found to contain the wrong species (Patyra 2025).
What’s different from most herbs here: Eleuthero doesn’t have 3,000 years of Ayurvedic documentation or deep European folk history. Its primary evidence base is 20th-century Soviet institutional research. When you buy eleuthero, you’re partly buying a Cold War pharmacological legacy — which is historically interesting but means the evidence structure is unusual.
Dry extract capsules (most convenient, most used in modern trials):
Liquid extract or tincture:
Decoction (traditional TCM preparation):
Take in the morning or early afternoon. Eleuthero’s adaptogenic activity leans stimulating — some people notice irritability or disrupted sleep when taken in the evening.
Weeks 1–2: 100 mg dry extract OR 1 mL liquid extract once daily. Let your system adjust; watch for any blood pressure or mood effects.
Weeks 3–8: 200–400 mg dry extract OR 2–3 mL liquid extract daily. This is the regulatory consensus range and covers most positive studies.
For endurance specifically (based on Kuo 2010): 800 mg/day for minimum 8 weeks — the crossover study showed no performance benefit until the full course was completed.
Take a 2–4 week break before repeating. Commission E explicitly allows repeated courses.
Before starting (1 week baseline):
During trial (compare Week 4 and Week 8 to baseline): Track the same markers. The most meaningful signal: afternoon energy and exercise recovery time. Eleuthero’s evidence points to sustained performance, not peak performance.
If you have a blood pressure cuff, check at baseline, Week 2, and Week 4 — particularly if you have any cardiovascular risk.
RED FLAGS — stop immediately:
People with moderate, not severe, fatigue. The Hartz 2004 subgroup that responded had less-severe fatigue — the interpretation is that eleuthero supports functional performance in people who are depleted but not crashed. Those with severe chronic fatigue showed no benefit.
Recreational athletes building endurance. Kuo 2010 (n=9) showed +12% VO2 peak and +23% endurance time in recreationally trained individuals. Small study, but real signal — and the glycogen-sparing metabolic shift is mechanistically plausible.
People doing sustained demanding work under chronic stress. The original Soviet use case: sustained performance in difficult conditions. Factory worker, not elite sprinter.
During convalescence. Both TCM tradition and Commission E support this; Cicero 2004 (n=20, 300 mg/day) showed improved social functioning at 4 weeks in elderly — the effect was gone by 8 weeks, suggesting early-recovery support.
What they report: “I just get through the afternoon without collapsing,” “Fewer colds during high-stress periods,” “Workouts don’t wipe me out for a day afterward.”
Elite or highly trained athletes. Null results in distance runners (Dowling 1996); worsened testosterone-to-cortisol ratio in competitive club athletes (Gaffney 2001). The evidence pattern consistently favors recreational over elite populations.
Severe chronic fatigue or burnout. The Hartz 2004 severe fatigue subgroup showed no benefit. If you’re significantly depleted, ashwagandha has stronger evidence for HPA axis support.
Those expecting dramatic, noticeable shifts. This is a subtle herb. “Adaptogen” implies support for baseline resilience, not acute relief.
If you don’t respond: Rhodiola has stronger and more consistent modern evidence overall. Ashwagandha is better supported for sleep and cortisol reduction. Eleuthero not working doesn’t mean adaptogens don’t work.
Eleuthero has one of the most severe quality problems in the commercial supplement market. This isn’t a mild caveat — it directly determines whether you’re doing a real experiment or just spending money.
The numbers:
The adulteration history: In the 1980s–90s, Periploca sepium (silk vine) was commonly substituted for eleuthero. Silk vine has different compounds — periplocoside A instead of eleutherosides — and was linked to adverse cardiovascular effects in pediatric patients when mislabeled as “Siberian ginseng.” Modern adulteration involves other Acanthopanax species substitution, which is harder to detect but still alters the active compound profile.
What to look for:
Avoid: Products labeled only as “Siberian ginseng” without the Latin name, no eleutheroside content declared, unusually low-cost sources without verification.
The Soviet clinical research used a standardized ethanolic extract at a specific dose. Modern unverified commercial products are a different substance.
Eleuthero is the herb that gave us the word “adaptogen” — coined for it, not borrowed from elsewhere. It has regulatory recognition from three major bodies, a substantial (if methodologically imperfect) Soviet research legacy, and coherent traditional use across East Asia. It also has mostly null results in modern Western RCTs.
Where it likely works: Moderate fatigue, recreational endurance support, sustained cognitive and physical performance under chronic stress. The Soviet use case — daily performance under difficult conditions — is probably still the best model. Subtle, consistent support rather than dramatic relief.
Where it doesn’t: Elite athletic performance, severe chronic fatigue, acute situations. If you need strong evidence, rhodiola or ashwagandha have it.
The non-negotiable: Quality is a genuine problem. Content varies 200-fold across commercial products; wrong species is found in 30% of Japanese market products. The experiment you’re running only works if you verify what you’re taking. Buy from a verified source with eleutheroside B + E content stated in mg, confirmed by third-party testing.
Take it in the morning. Don’t use it if you have hypertension. Run a real 8-week trial. Track what you’re measuring against. The most useful thing eleuthero may do is quietly and consistently help you get through hard days — which is exactly what it was built for.
Duration: Minimum 8 weeks. Kuo 2010 crossover showed no endurance benefit until the full 8-week course was completed. Commission E allows up to 3 months; EMA recommends up to 2 months. Take a 2–4 week break before repeating.
What to notice:
Take in the morning or early afternoon. Eleuthero leans stimulating rather than sedating — some people notice irritability or insomnia if taken late. Start low (100 mg dry extract or 1 mL liquid extract) for 2 weeks, then increase if well tolerated. Expect subtle effects, not dramatic ones. The original Soviet use was daily performance under difficult conditions, not acute relief.
Generally considered: caution
Contraindications:
Pregnancy/Nursing: Contraindicated in pregnancy (WHO, EMA). No safety data in breastfeeding; LactMed 2024 states 'most sources recommend against use.' Reported concerns include blood pressure elevation and potential glucose effects — both relevant in the perinatal period.
Generally well-tolerated short-term. No serious adverse events in any Western RCT — Weng 2007 reported 3 adverse events in eleuthero group vs 12 in fluoxetine group over 6 weeks. Reported side effects at standard doses: irritability, insomnia (take in morning), headache, mild GI discomfort. Use with caution with anticoagulants (possible additive bleeding risk), antihypertensives (may antagonize control), antidiabetics (bidirectional glucose effects observed across studies). No comprehensive CYP450 interaction data exists — gap in the literature. Duration limits are precautionary, not based on documented harm with longer use.